{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:24:10Z","timestamp":1648902250688},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00063-012-0141-y","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T08:54:13Z","timestamp":1377161653000},"page":"549-554","source":"Crossref","is-referenced-by-count":0,"title":["Vorhofflimmern auf der Intensivstation"],"prefix":"10.1007","volume":"108","author":[{"given":"G.","family":"Heinz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"141_CR1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s001340051280","volume":"26","author":"Knotzer","year":"2000","unstructured":"Knotzer H, Mayr A, Ulmer H et al (2000) Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med 26(7):908\u2013914","journal-title":"Intensive Care Med"},{"key":"141_CR2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s001340101043","volume":"27","author":"Reinelt","year":"2001","unstructured":"Reinelt P, Delle Karth G, Geppert A, Heinz G (2001) Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med 27(9):1466\u20131473","journal-title":"Intensive Care Med"},{"key":"141_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","volume":"178","author":"Annane","year":"2008","unstructured":"Annane D, S\u00e9bille V, Duboc D et al (2008) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178(1):20\u201325","journal-title":"Am J Respir Crit Care Med"},{"key":"141_CR4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00134-003-1735-x","volume":"29","author":"Delle","year":"2003","unstructured":"Delle Karth G, Reinelt P, Buberl A et al (2003) Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU. Intensive Care Med 29(6):963\u2013968","journal-title":"Intensive Care Med"},{"key":"141_CR5","first-page":"854","volume":"48","author":"European","year":"4","unstructured":"European Heart Rhythm Association; Heart Rhythm Society, American College of Cardiology et al (o J) ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2013 executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48(4):854\u2013906","journal-title":"J Am Coll Cardiol"},{"key":"141_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.CCM.0000048627.39686.79","volume":"31","author":"Mayr","year":"2003","unstructured":"Mayr A, Ritsch N, Knotzer H et al (2003) Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med 31(2):401\u2013405","journal-title":"Crit Care Med"},{"key":"141_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1460-9592.2001.00191.x","volume":"24","author":"Kowey","year":"2001","unstructured":"Kowey PR, Stebbins D, Igidbashian L et al (2001) Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol 24:191\u2013193","journal-title":"Pacing Clin Electrophysiol"},{"key":"141_CR8","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1378\/chest.128.2_suppl.61S","volume":"128","author":"McKeown","year":"2005","unstructured":"McKeown P, Epstein AE, American College of Chest Physicians (2005) Future directions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128(Suppl 2):61S\u201364S","journal-title":"Chest"},{"key":"141_CR9","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"European","year":"2010","unstructured":"European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369\u2013429","journal-title":"Eur Heart J"},{"key":"141_CR10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347(23):1825\u20131833","journal-title":"N Engl J Med"},{"key":"141_CR11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","volume":"356","author":"Hohnloser","year":"2000","unstructured":"Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation \u2013 Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356(9244):1789\u20131794","journal-title":"Lancet"},{"key":"141_CR12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","volume":"347","author":"Van","year":"2002","unstructured":"Van Gelder IC, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347(23):1834\u20131840","journal-title":"N Engl J Med"},{"key":"141_CR13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","volume":"29","author":"Delle","year":"2001","unstructured":"Delle Karth G, Geppert A, Neunteufl T et al (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29(6):1149\u20131153","journal-title":"Crit Care Med"},{"key":"141_CR14","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1097\/CCM.0b013e3181a02f56","volume":"37","author":"Siu","year":"2009","unstructured":"Siu CW, Lau CP, Lee WL et al (2009) Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Crit Care Med 37(7):2174\u20132179","journal-title":"Crit Care Med"},{"key":"141_CR15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324(12):781\u2013788","journal-title":"N Engl J Med"},{"key":"141_CR16","doi-asserted-by":"crossref","unstructured":"The Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227\u2013233. http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJM199207233270403. Zugegriffen: 08. Juli 2013","DOI":"10.1056\/NEJM199207233270403"},{"key":"141_CR17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","volume":"340","author":"Oral","year":"1999","unstructured":"Oral H, Souza JJ, Michaud GF et al (1999) Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 340(24):1849\u20131854","journal-title":"N Engl J Med"},{"key":"141_CR18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","volume":"117","author":"Roy","year":"2008","unstructured":"Roy D, Pratt CM, Torp-Pedersen C et al (2008) Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation 117(12):1518\u20131525","journal-title":"Circulation"},{"key":"141_CR19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCEP.109.870204","volume":"2","author":"Kowey","year":"2009","unstructured":"Kowey PR, Dorian P, Mitchell LB et al (2009) Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2(6):652\u2013659","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"141_CR20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.amjcard.2010.06.054","volume":"106","author":"Pratt","year":"2010","unstructured":"Pratt CM, Roy D, Torp-Pedersen C et al (2010) Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol 106(9):1277\u20131283","journal-title":"Am J Cardiol"},{"key":"141_CR21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ahj.2010.02.035","volume":"159","author":"Stiell","year":"2010","unstructured":"Stiell IG, Roos JS, Kavanagh KM, Dickinson G (2010) A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm. Am Heart J 159(6):1095\u20131101","journal-title":"Am Heart J"},{"key":"141_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2010.07.046","volume":"57","author":"Camm","year":"2011","unstructured":"Camm AJ, Capucci A, Hohnloser SH et al (2011) A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol 57(3):313\u2013321","journal-title":"J Am Coll Cardiol"},{"key":"141_CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/euhj.1999.1734","volume":"21","author":"Capucci","year":"2000","unstructured":"Capucci A, Villani GQ, Aschieri D et al (2000) Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 21(1):66\u201373","journal-title":"Eur Heart J"},{"key":"141_CR24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"Klein","year":"2001","unstructured":"Klein AL, Grimm RA, Murray RD et al (2001) Assessment of cardioversion using transesophageal echocardiography investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344(19):1411\u20131420","journal-title":"N Engl J Med"},{"key":"141_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.200804-554ED","volume":"178","author":"Heinz","year":"2008","unstructured":"Heinz G (2008) Arrhythmias in the ICU: what do we know? Am J Respir Crit Care Med 178(1):1\u20132","journal-title":"Am J Respir Crit Care Med"},{"key":"141_CR26","first-page":"313","volume":"11","author":"Darius","year":"2004","unstructured":"Darius H, Hester K, Sanderink GJ, Paar WD (2004) Antithrombotische Therapie mit niedermolekularen Heparinen bei Niereninsuffizienz. J Kardiol 11:313\u2013316","journal-title":"J Kardiol"},{"key":"141_CR27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(02)07920-5","volume":"359","author":"D\u00f6rffler-Melly","year":"2002","unstructured":"D\u00f6rffler-Melly J, Jonge E de, Pont AC et al (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359(9309):849\u2013850","journal-title":"Lancet"},{"key":"141_CR28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.CCM.0000059725.60509.A0","volume":"31","author":"Priglinger","year":"2003","unstructured":"Priglinger U, Delle Karth G, Geppert A et al (2003) Prophylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill? Crit Care Med 31(5):1405\u20131409","journal-title":"Crit Care Med"},{"key":"141_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/cc12602","volume":"17","author":"Heinz","year":"2013","unstructured":"Heinz G, Priglinger U, Pabinger I (2013) Anti Xa activities following 5000 and 7500\u00a0IU of SC dalteparin in critically ill patients and 5000\u00a0IU in medical patients \u2013 a prospective randomized study. Crit Care 17(Suppl 2):133","journal-title":"Crit Care"},{"key":"141_CR30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2125.2012.04285.x","volume":"74","author":"Ghazaleh","year":"2012","unstructured":"Ghazaleh Gouya G, Palkovits S, Kapiotis S et al (2012) Bioactivity of enoxaparin in critically ill patients with normal renal function: results of a prospective, controlled open-label study. Br J Clin Pharmacol 74(5):806\u2013814","journal-title":"Br J Clin Pharmacol"},{"key":"141_CR31","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","volume":"127","author":"American","year":"2013","unstructured":"American College of Cardiology Foundation, American Heart Association, European Society of Cardiology et al (2013) Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation 127(18):1916\u20131926","journal-title":"Circulation"},{"key":"141_CR32","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Hedgepeth","year":"2007","unstructured":"Hedgepeth CM, Molhoek P, Verheugt FW et al (2007) Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment \u2013 elevation acute coronary syndrome results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome \u2013 Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116:1647\u20131652","journal-title":"Circulation"},{"key":"141_CR33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2011.04.017","volume":"108","author":"Miles","year":"2011","unstructured":"Miles RH, Passman R, Murdock DK (2011) Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 108:673\u2013676","journal-title":"Am J Cardiol"},{"key":"141_CR34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199712183372501","volume":"337","author":"Daoud","year":"1997","unstructured":"Daoud EG, Strickberger SA, Man KC et al (1997) Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337(25):1785\u20131791","journal-title":"N Engl J Med"},{"key":"141_CR35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(00)04196-9","volume":"357","author":"Giri","year":"2001","unstructured":"Giri S, White CM, Dunn AB et al (2001) Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 357(9259):830\u2013836","journal-title":"Lancet"},{"key":"141_CR36","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","volume":"27","author":"Burgess","year":"2006","unstructured":"Burgess DC, Kilborn MJ, Keech AC (2006) Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 27:2846\u20132857","journal-title":"Eur Heart J"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-012-0141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-012-0141-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-012-0141-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T17:16:48Z","timestamp":1563729408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-012-0141-y"}},"subtitle":["Eigene Entit\u00e4t \u2013 spezielle Behandlung?"],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1007\/s00063-012-0141-y","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}